Cumberland Pharmaceuticals Inc (CPIX): Revenue
$44.52M
Year ended 2025-12-31
$39.90M
Trailing 12 months to 2026-06-30
+2.0%
3-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $44.52M | +17.6% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | $37.87M | -4.3% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | $39.55M | -5.9% | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | $42.01M | n/c | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | $35.05M | -2.2% | 2023-03-13, From 2021-01-01 |
| 2020-12-31 | $35.84M | +10.6% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $32.41M | +12.5% | 2022-03-11, From 2019-01-01 |
| 2018-12-31 | $28.80M | n/c | 2021-03-12, From 2018-01-01 |
| 2017-12-31 | $40.38M | +24.3% | 2020-03-20, From 2017-01-01 |
| 2016-12-31 | $32.48M | n/a | 2019-03-12, From 2016-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $44.52M | +17.6% |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | $44.55M | -22.6% |
| Integrated Biopharma Inc (INBP) | 2026-06-30 | $43.87M | -19.3% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $43.77M | +589.9% |
| Septerna, Inc. (SEPN) | 2025-12-31 | $45.95M | n/m |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | $46.02M | -89.4% |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | $42.73M | -60.5% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $41.70M | +11.7% |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | $48.47M | -57.7% |
Compare CPIX, AQST, INBP, XLO side by side · Screen every company in Pharmaceutical Preparations ↗